GlaxoSmithKline's COPD drug Anoro receives European green light

[riky]

GlaxoSmithKline's COPD drug Anoro receives European green light

<p><a href="http://news.yahoo.com/glaxosmithkline-39-copd-drug-anoro-receives-european-green-133037366--finance.html"><img src="http://l2.yimg.com/bt/api/res/1.2/ZAhtfWmCA56LFFLfFA7.Dg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-02-20T133037Z_1_CBREA1J11J400_RTROPTP_2_GSK-CHINA.JPG" width="130" height="86" alt="The GlaxoSmithKline building is pictured in Hounslow, west London" align="left" title="The GlaxoSmithKline building is pictured in Hounslow, west London" border="0" /></a>Anoro, a combination drug for chronic obstructive pulmonary disease (COPD) developed by GlaxoSmithKline and Theravance, has received the green light from European regulators, the companies said on Thursday. It is expected to generate sales of more than $2 billion a year by 2018, according to the average estimate of six analysts polled by Thomson Reuters.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login